Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape
Title: | Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape |
---|---|
Authors: | Francesca Fortini, Francesco Vieceli Dalla Sega, Luisa Marracino, Paolo Severi, Claudio Rapezzi, Paola Rizzo, Roberto Ferrari |
Source: | Biomedicines, Vol 9, Iss 8, p 997 (2021) |
Publisher Information: | MDPI AG, 2021. |
Publication Year: | 2021 |
Collection: | LCC:Biology (General) |
Subject Terms: | endothelial dysfunction, pyroptosis, Notch, COVID-19, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, Biology (General), QH301-705.5 |
More Details: | Endothelial dysfunction characterizes every aspect of the so-called cardiovascular continuum, a series of events ranging from hypertension to the development of atherosclerosis and, finally, to coronary heart disease, thrombus formation, myocardial infarction, and heart failure. Endothelial dysfunction is the main prognostic factor for the progression of vascular disorders, which responds to drug intervention and lifestyle changes. Virtually all of the drugs used to prevent cardiovascular disorders, such as long-used and new antilipidemic agents and inhibitors of angiotensin enzyme (ACEi), exert an important effect on the endothelium. Endothelial dysfunction is a central feature of coronavirus disease -19 (COVID-19), and it is now clear that life-risk complications of the disease are prompted by alterations of the endothelium induced by viral infection. As a consequence, the progression of COVID-19 is worse in the subjects in whom endothelial dysfunction is already present, such as elderly, diabetic, obese, and hypertensive patients. Importantly, circulating biomarkers of endothelial activation and injury predict the severity and mortality of the disease and can be used to evaluate the efficacy of treatments. The purpose of this review is to provide updates on endothelial function by discussing its clinical relevance in the cardiovascular continuum, the latest insights from molecular and cellular biology, and their implications for clinical practice, with a focus on new actors, such as the Notch signaling and emerging therapies for cardiovascular disease. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2227-9059 |
Relation: | https://www.mdpi.com/2227-9059/9/8/997; https://doaj.org/toc/2227-9059 |
DOI: | 10.3390/biomedicines9080997 |
Access URL: | https://doaj.org/article/723e619f75af42a3895c7fe6a48ea6ac |
Accession Number: | edsdoj.723e619f75af42a3895c7fe6a48ea6ac |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=22279059&ISBN=&volume=9&issue=8&date=20210801&spage=997&pages=997-997&title=Biomedicines&atitle=Well-Known%20and%20Novel%20Players%20in%20Endothelial%20Dysfunction%3A%20Updates%20on%20a%20Notch%28ed%29%20Landscape&aulast=Francesca%20Fortini&id=DOI:10.3390/biomedicines9080997 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/723e619f75af42a3895c7fe6a48ea6ac Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.723e619f75af42a3895c7fe6a48ea6ac RelevancyScore: 902 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 901.913452148438 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Francesca+Fortini%22">Francesca Fortini</searchLink><br /><searchLink fieldCode="AR" term="%22Francesco+Vieceli+Dalla+Sega%22">Francesco Vieceli Dalla Sega</searchLink><br /><searchLink fieldCode="AR" term="%22Luisa+Marracino%22">Luisa Marracino</searchLink><br /><searchLink fieldCode="AR" term="%22Paolo+Severi%22">Paolo Severi</searchLink><br /><searchLink fieldCode="AR" term="%22Claudio+Rapezzi%22">Claudio Rapezzi</searchLink><br /><searchLink fieldCode="AR" term="%22Paola+Rizzo%22">Paola Rizzo</searchLink><br /><searchLink fieldCode="AR" term="%22Roberto+Ferrari%22">Roberto Ferrari</searchLink> – Name: TitleSource Label: Source Group: Src Data: Biomedicines, Vol 9, Iss 8, p 997 (2021) – Name: Publisher Label: Publisher Information Group: PubInfo Data: MDPI AG, 2021. – Name: DatePubCY Label: Publication Year Group: Date Data: 2021 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Biology (General) – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22endothelial+dysfunction%22">endothelial dysfunction</searchLink><br /><searchLink fieldCode="DE" term="%22pyroptosis%22">pyroptosis</searchLink><br /><searchLink fieldCode="DE" term="%22Notch%22">Notch</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22angiotensin+converting+enzyme+inhibitors%22">angiotensin converting enzyme inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22angiotensin+II+receptor+blockers%22">angiotensin II receptor blockers</searchLink><br /><searchLink fieldCode="DE" term="%22Biology+%28General%29%22">Biology (General)</searchLink><br /><searchLink fieldCode="DE" term="%22QH301-705%2E5%22">QH301-705.5</searchLink> – Name: Abstract Label: Description Group: Ab Data: Endothelial dysfunction characterizes every aspect of the so-called cardiovascular continuum, a series of events ranging from hypertension to the development of atherosclerosis and, finally, to coronary heart disease, thrombus formation, myocardial infarction, and heart failure. Endothelial dysfunction is the main prognostic factor for the progression of vascular disorders, which responds to drug intervention and lifestyle changes. Virtually all of the drugs used to prevent cardiovascular disorders, such as long-used and new antilipidemic agents and inhibitors of angiotensin enzyme (ACEi), exert an important effect on the endothelium. Endothelial dysfunction is a central feature of coronavirus disease -19 (COVID-19), and it is now clear that life-risk complications of the disease are prompted by alterations of the endothelium induced by viral infection. As a consequence, the progression of COVID-19 is worse in the subjects in whom endothelial dysfunction is already present, such as elderly, diabetic, obese, and hypertensive patients. Importantly, circulating biomarkers of endothelial activation and injury predict the severity and mortality of the disease and can be used to evaluate the efficacy of treatments. The purpose of this review is to provide updates on endothelial function by discussing its clinical relevance in the cardiovascular continuum, the latest insights from molecular and cellular biology, and their implications for clinical practice, with a focus on new actors, such as the Notch signaling and emerging therapies for cardiovascular disease. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2227-9059 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://www.mdpi.com/2227-9059/9/8/997; https://doaj.org/toc/2227-9059 – Name: DOI Label: DOI Group: ID Data: 10.3390/biomedicines9080997 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/723e619f75af42a3895c7fe6a48ea6ac" linkWindow="_blank">https://doaj.org/article/723e619f75af42a3895c7fe6a48ea6ac</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.723e619f75af42a3895c7fe6a48ea6ac |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.723e619f75af42a3895c7fe6a48ea6ac |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/biomedicines9080997 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: 997 Subjects: – SubjectFull: endothelial dysfunction Type: general – SubjectFull: pyroptosis Type: general – SubjectFull: Notch Type: general – SubjectFull: COVID-19 Type: general – SubjectFull: angiotensin converting enzyme inhibitors Type: general – SubjectFull: angiotensin II receptor blockers Type: general – SubjectFull: Biology (General) Type: general – SubjectFull: QH301-705.5 Type: general Titles: – TitleFull: Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Francesca Fortini – PersonEntity: Name: NameFull: Francesco Vieceli Dalla Sega – PersonEntity: Name: NameFull: Luisa Marracino – PersonEntity: Name: NameFull: Paolo Severi – PersonEntity: Name: NameFull: Claudio Rapezzi – PersonEntity: Name: NameFull: Paola Rizzo – PersonEntity: Name: NameFull: Roberto Ferrari IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 22279059 Numbering: – Type: volume Value: 9 – Type: issue Value: 8 Titles: – TitleFull: Biomedicines Type: main |
ResultId | 1 |